clenbuterol has been researched along with Sarcopenia in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Uremic sarcopenia is caused by ageing, malnutrition, and chronic inflammation, but the molecular mechanism and potential therapeutics have not been fully elucidated yet." | 1.62 | β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice. ( Higashihara, T; Inagi, R; Maruyama, T; Nangaku, M; Nishi, H; Takemura, K; Tanaka, T; Watanabe, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashihara, T | 1 |
| Nishi, H | 1 |
| Takemura, K | 1 |
| Watanabe, H | 1 |
| Maruyama, T | 1 |
| Inagi, R | 1 |
| Tanaka, T | 1 |
| Nangaku, M | 1 |
1 other study available for clenbuterol and Sarcopenia
| Article | Year |
|---|---|
β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Ascorbic Acid; Cell Size; Clenbuterol; Female; Indican | 2021 |